BRAZIL · ECONOMY Key Facts —The approval: Brazil's health regulator cleared Ozivy, the country's first home-grown version of the drug behind Ozempic.
Daily Brief
The morning intel from across Latin America. Free.
By subscribing you agree to our privacy policy. We never share your email.
BRAZIL · ECONOMY
Key Facts
Brazil will pilot Ozempic-style weight-loss drugs in its public health system, a demand signal for Novo Nordisk and Eli Lilly…
El medicamento se comercializará bajo el nombre Ozivy y llegará al mercado brasileño “en unas pocas semanas”.
A Brazilian drugmaker filed to launch its own version of the blockbuster weight-loss and diabetes drug, taking aim at a market…
La Agencia Nacional de Vigilancia Sanitaria (Anvisa) de Brasil autorizó la fabricación y comercialización de una copia sintética…
El nuevo fármaco con semaglutida llegará al mercado brasileño en las próximas semanas tras vencer la patente del medicamento…
A Mounjaro price cut in Brazil, days before a cheaper local pen arrives, has touched off a price war in the country's…
